Clinically Actionable Insights into Initial and Matched Recurrent Glioblastomas to Inform Novel Treatment Approaches.

Ellis, H P; McInerney, C E; Schrimpf, D; Sahm, F; Stupnikov, A; Wadsley, M; Wragg, C; White, P; Prise, K M; McArt, D G; Kurian, K M

Ellis, H P; McInerney, C E; Schrimpf, D; Sahm, F; Stupnikov, A; Wadsley, M; Wragg, C; White, P; Prise, K M; McArt, D G; Kurian, K M.

Afiliação

Ellis HP; Brain Tumour Research Centre, University of Bristol, Bristol, UK.
McInerney CE; Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK.
Schrimpf D; Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany.
Sahm F; Department of Neuropathology, Institute of Pathology, Ruprecht-Karls-University Heidelberg, Heidelberg, Germany.
Stupnikov A; Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK.
Wadsley M; Department of Oncology, School of Medicine, Johns Hopkins University, Baltimore, MD 21287, USA.
Wragg C; Bristol Genetics Laboratory, North Bristol NHS Trust, Bristol, UK.
White P; Bristol Genetics Laboratory, North Bristol NHS Trust, Bristol, UK.
Prise KM; Applied Statistics Group, University of the West of England, Bristol, UK.
McArt DG; Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK.
Kurian KM; Centre for Cancer Research and Cell Biology, Queen's University, Belfast, UK.

J Oncol ; 2019: 4878547, 2019.

Article em En | MEDLINE | ID: mdl-32082376

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Oncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google